Conspectus Electrochemical organic oxidation reactions are highly appealing because
protons are often effective terminal electron acceptors, thereby avoiding undesirable …

Rosuvastatin/ezetimibe combines two lipid-lowering agents: rosuvastatin, an HMG-CoA
reductase inhibitor (ie statin) with particularly strong inhibitory effects on hepatic cholesterol …

Introduction Although statin therapy is a powerful lipid-lowering strategy, only one-fifth of
statin users currently reach their lipid goals. In addition, statin treatment alone has relatively …

Periodontitis is a local and systemic inflammatory condition and a risk factor of
atherosclerosis, but no studies investigated the effect of a statin on atherogenesis affected …

The objectives of this study were to optimize the formula of the self-nanoemulsifying drug
delivery system (SNEDDS) containing rosuvastatin and to evaluate its physicochemical …

Elagolix is an oral gonadotropin‐releasing hormone receptor antagonist indicated for the
management of endometriosis‐associated pain and in combination with estradiol …

This study investigated the impact of SLCO1B1 genotype on rosuvastatin systemic exposure
in hypercholesterolemic children and adolescents. Participants (8–21 years) with at least …

A backpropagation artificial neural network (BPANN) model was established for the
prediction of the plasma concentration and pharmacokinetic parameters of rosuvastatin …

Statins are a class of drugs that act lowering lipid levels by inhibiting cholesterol
biosynthesis. Additionally, statins can act by “pleiotropic effects”, related to the inhibition of …

Statins are used to lower cholesterol and prevent cardiovascular disease. Musculoskeletal
side effects known as statin associated musculoskeletal symptoms (SAMS), are reported in …